| Orders | Qty | Bid |
|---|---|---|
| 1 | 4 | 1927.4 |
| 1 | 4 | 1927.3 |
| 3 | 10 | 1927.2 |
| 2 | 4 | 1927.1 |
| 3 | 7 | 1927 |
| Ask | Qty | Orders |
|---|---|---|
| 1928.2 | 1 | 6 |
| 1928.5 | 1 | 1 |
| 1928.7 | 1 | 11 |
| 1929 | 3 | 128 |
| 1929.3 | 1 | 7 |

Ipca Laboratories Ltd has delivered a 66.64% absolute return over the past 5 years, equivalent to a CAGR of 10.75% per annum. The stock was priced at ₹1,199.59 in Sep 2021 and has risen to ₹1,999.00 as of 19 Sep 2026. An investment of ₹1,00,000 in Ipca Laboratories Ltd five years ago would be worth ₹1,66,640.00 today.
Ipca Laboratories Ltd has delivered 39.46% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹2,038.00 on 18 Sep 2026 and a 52-week low of ₹1,251.60 on 24 Oct 2025. It is currently trading at ₹1,999.00 as of 19 Sep 2026.
The all-time high (ATH) for Ipca Laboratories Ltd was ₹2,009.60, recorded on 18 Sep 2026. At the current price of ₹1,999.00, the stock is trading 0.53% below its all-time high. The all-time low recorded was ₹104.60 on 07 Jan 2010.
Yes,Ipca Laboratories Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 18.00 per share between FY2022 and FY2026, with the most recent dividend of ₹6.00 per share for May 26, with an ex-dividend date of 07 Aug 2026. At the current market price of ₹1,999.00, the trailing dividend yield of Ipca Laboratories Ltd stands at 6.00%.
As of 19 Sep 2026, the share price of Ipca Laboratories Ltd is ₹1,999.00 on the NSE and ₹1,986.10 on the BSE. The stock opened at ₹1,972.30, touched a high of ₹2,038.00 and a low of ₹1,898.00 during today's session.
Over the last 6 months, Ipca Laboratories Ltd has given a return of 30.12%. The stock was priced at ₹1,544.40 on 19 Mar 2026 and has Rise to ₹1,999.00 as of 19 Sep 2026, a change of ₹454.60 per share.
Ipca Laboratories Ltd has delivered a return of 26.72% over the last 3 months. The stock was trading at ₹1,585.80 on 19 Jun 2026 and is currently at ₹1,999.00 as of 19 Sep 2026, reflecting a Gain of ₹413.20 per share over this period.
The intraday high for Ipca Laboratories Ltd on the NSE today (19 Sep 2026) was ₹2,038.00. This compares to the 52-week high of ₹2,038.00 recorded on 18 Sep 2026. Today's high was 0.00% above the 52-week high.
The intraday low for Ipca Laboratories Ltd on the NSE today was ₹1,898.00. The stock's 52-week low stands at ₹1,251.60, recorded on 24 Oct 2025. Today's low is 51.65% above the 52-week low, indicating the stock is trading well above its yearly lows.
For Q1 FY27, Ipca Laboratories Ltd reported: Revenue (Net Sales): ₹21192.40 Cr - Up 16.80% year-on-year from ₹18143.50 Cr in Q4 FY26. Net Income (PAT): ₹3732.90 Cr - Up 42.32% year-on-year from ₹2622.90 Cr in Q4 FY26.